memorandum department of health and human services public service food drug administration center for evaluation research pid d050100 date may 10 th 2006 from lcdr david moeny usphs r ph use specialist sigal kaplan d b pharm pharmacoepidemiologist division surveillance communication support hfd 410 through toni piazza hepp acting director to m dianne murphy md office pediatric therapeutics opt oiasi the commissioner solomon iyasu mph drugs development 960 counter terrorism subject one year post exclusivity review data invanz ertapenem sodium injection nda 21 337 grant february 11 2005 this document contains proprietary obtained by fda under contract information cannot be released non personnel without contractor approval cder epidemiology executive summary consult examines inpatient utilization trends in population aged 0 16 years with primary focus on patterns before
